BRIEF published on 11/18/2025 at 18:35, 16 days 10 hours ago GenOway: Accelerated Growth in China by genOway Shanghai Profitability China Growth Immuno-oncology GenOway
BRIEF published on 09/22/2025 at 18:05, 2 months 12 days ago Solid half-year results for genOway despite declining revenue EBITDA Half-year Results Investments GenOway Route50+
BRIEF published on 07/22/2025 at 18:05, 4 months 13 days ago GenOway's first half 2025 results: revenue down 10% Investment Growth Turnover GenOway ROUTE 50+
BRIEF published on 03/27/2025 at 18:00, 8 months 8 days ago GenOway: Solid 2024 Results and Strategic Ambitions with ROUTE 50+ Financial Results Biotechnology Strategic Plan Organic Growth GenOway
BRIEF published on 01/20/2025 at 18:05, 10 months 15 days ago GenOway Growth: Analysis of the year 2024 and Outlook 2025 Strategy Growth Preclinical Walk GenOway
BRIEF published on 11/04/2024 at 18:05, 1 year 1 month ago GenOway's preclinical models gain ground in the fight against obesity Pharmaceutical Obesity GenOway Metabolism Preclinical Models
BRIEF published on 09/23/2024 at 18:05, 1 year 2 months ago Half-year results 2024: genOway achieves its growth objectives EBITDA Biotechnology Strategic Plan R&D Growth
BRIEF published on 07/18/2024 at 18:05, 1 year 4 months ago GenOway shows growth of 15% in the first half of 2024 Sales Growth Preclinical GenOway Route50+
BRIEF published on 07/04/2024 at 18:05, 1 year 5 months ago Half-yearly review of the GENOWAY liquidity contract Liquidity Transactions BNP Paribas GenOway Half-yearly Review
BRIEF published on 06/25/2024 at 18:00, 1 year 5 months ago Promising development for the genOway Shanghai joint venture Joint Venture China Immuno-oncology Preclinical Research GenOway
Published on 12/05/2025 at 02:35, 2 hours 48 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 23 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 18 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 23 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 32 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 23 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 22 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
